BIOA
NASDAQ
$22.32
BioAge Labs Inc (BIOA)
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The company is headquartered in Montreal, Canada.
Sector:
Healthcare
Buy
Target: $49.50 (+121.77%)
Market Cap
$1.01B
Free Cash Flow Yield
-8.80%
Beta (5Y)
1.04
Price Chart
Valuation
Market Cap$1.01B
P/S97.82
P/B2.67
Profitability
Total Revenue (TTM)$10M
Gross Profit (TTM)-$73M
EBITDA-$102M
Operating Margin-915%
EPS-$2.36
Financial Health
Debt-to-Equity0.3%
Free Cash Flow Yield-8.80%
Growth & Risk
Beta (5Y)1.04
Sharpe Ratio2.19